有机硫化合物是指含有硫原子的有机化合物。这些化合物在自然界中广泛存在,在医药、农药和材料科学等领域有着重要的应用。有机硫化合物因其化学性质独特,在药物设计、合成化学以及材料制备方面扮演着重要角色。
1. 结构与分类有机硫化合物可以按硫的连接方式分为饱和和不饱和类,如二硫化物、噻吩衍生物、砜等。常见的结构类型有:
许多有机硫化合物在生物学上有重要功能或应用潜力。例如:
有机硫化合物可通过多种途径合成:
有机硫化合物的应用广泛:
尽管有机硫化合物具有许多潜在益处,但其生产和使用也可能对环境造成影响。因此,在设计和合成这些化合物时需要考虑可持续性和环保性因素。
以上是对有机硫化合物的简单介绍,包括它们的结构、生物学活性、合成方法及其应用领域等基本信息。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
—— | methyl (2R)-2-[5-[(3-fluorophenyl)methyl]-1,4-dimethyl-6-oxopyrimidin-2-yl]sulfanylpropanoate | —— | C17H19FN2O3S |
|
—— | N-[(1S,2R,3R)-2,3-dimethylcyclohexyl]-2-[[5-(3-methylanilino)-1,3,4-thiadiazol-2-yl]sulfanyl]acetamide | —— | C19H26N4OS2 |
|
—— | methyl (2S)-2-[5-[(3-fluorophenyl)methyl]-1,4-dimethyl-6-oxopyrimidin-2-yl]sulfanylpropanoate | —— | C17H19FN2O3S |
|
—— | (2R,6S)-2,6-dimethyl-4-(4-phenylsulfanylbutyl)morpholin-4-ium | —— | C16H26NOS+ |
|
—— | 4-(4-Phenylsulfanylbutyl)morpholin-4-ium | —— | C14H22NOS+ |
|
—— | (R)-[4-methyl-5-[(5-phenyl-1,3,4-oxadiazol-2-yl)methylsulfanyl]-1,2,4-triazol-3-yl]-phenylmethanol | —— | C19H17N5O2S |
|
—— | N-[(1S,2R,3R)-2,3-dimethylcyclohexyl]-2-[(4-methyl-6-oxo-1H-pyrimidin-2-yl)sulfanyl]acetamide | —— | C15H23N3O2S |
|
—— | 2-[[4-ethyl-5-(2-methylfuran-3-yl)-1,2,4-triazol-3-yl]sulfanyl]-N-[(1R,2S)-2-methylcyclohexyl]acetamide | —— | C18H26N4O2S |
|
—— | N-(furan-2-ylmethyl)-2-[[5-(2-methylfuran-3-yl)-4-[[(2R)-oxolan-2-yl]methyl]-1,2,4-triazol-3-yl]sulfanyl]acetamide | —— | C19H22N4O4S |
|
—— | 2-[[4-ethyl-5-(2-methylfuran-3-yl)-1,2,4-triazol-3-yl]sulfanyl]-N-[(1S,2S)-2-methylcyclohexyl]acetamide | —— | C18H26N4O2S |
|
—— | N-[(2S)-butan-2-yl]-2-[[5-(2-methylfuran-3-yl)-4-[(1S)-1-phenylethyl]-1,2,4-triazol-3-yl]sulfanyl]acetamide | —— | C21H26N4O2S |
|
—— | 2-[[5-(2-methylfuran-3-yl)-4-[[(2R)-oxolan-2-yl]methyl]-1,2,4-triazol-3-yl]sulfanyl]-1-morpholin-4-ylethanone | —— | C18H24N4O4S |
|
—— | (2R)-N-[(Z)-4-oxopentan-2-ylideneamino]-2-[(5-pyridin-4-yl-1,3,4-oxadiazol-2-yl)sulfanyl]propanamide | —— | C15H17N5O3S |
|
—— | 3-[4-amino-3-[(2-chlorophenyl)methylsulfanyl]-5-oxo-1,2,4-triazin-6-yl]propanoic Acid | —— | C13H13ClN4O3S |
|
—— | 1-(3,4-Difluorophenyl)-3-[(2-fluorophenyl)methylsulfanyl]pyrazin-2-one | —— | C17H11F3N2OS |
|
—— | 1-(3,4-difluorophenyl)-3-((4-methylbenzyl)thio)pyrazin-2(1H)-one | —— | C18H14F2N2OS |
|
—— | N-benzyl-2-[4-(3,4-difluorophenyl)-3-oxopyrazin-2-yl]sulfanylacetamide | —— | C19H15F2N3O2S |
|
—— | 2-[4-(3,4-difluorophenyl)-3-oxopyrazin-2-yl]sulfanyl-N-[(4-fluorophenyl)methyl]acetamide | —— | C19H14F3N3O2S |
|
—— | 3-(Benzylsulfanyl)-1-(3,4-difluorophenyl)-1,2-dihydropyrazin-2-one | —— | C17H12F2N2OS |
|
—— | 2-[4-(3,4-difluorophenyl)-3-oxopyrazin-2-yl]sulfanyl-N-(3-methylbutyl)acetamide | —— | C17H19F2N3O2S |
|
—— | (2S)-N-[2-[(2-chlorophenyl)methylsulfanyl]ethyl]-2-(4-chlorophenyl)sulfanylpropanamide | —— | C18H19Cl2NOS2 |
|
—— | Methyl 2-[6-amino-3,5-dicyano-4-(2-methylpropyl)pyridin-1-ium-2-yl]sulfanylacetate | —— | C14H17N4O2S+ |
|
—— | 2-(4-methylphenyl)sulfanyl-N-[[(2R)-oxolan-2-yl]methyl]ethanamine | —— | C14H21NOS |
|
—— | 2-(4-methylphenyl)sulfanyl-N-[[(2S)-oxolan-2-yl]methyl]ethanamine | —— | C14H21NOS |
|
—— | (2R)-2-(4-chlorophenyl)sulfanyl-N-(2-morpholin-4-ylethyl)propanamide | —— | C15H21ClN2O2S |
|
—— | 1-Methyl-4-[4-(4-methylphenyl)sulfanylbutyl]piperazine-1,4-diium | —— | C16H28N2S+2 |
|
—— | (2R,6R)-2,6-dimethyl-4-[2-(4-methylphenyl)sulfanylethyl]morpholine | —— | C15H23NOS |
|
—— | 2-[[5-(3-Methylanilino)-1,3,4-thiadiazol-2-yl]sulfanyl]-1-pyrrolidin-1-ylethanone | —— | C15H18N4OS2 |
|
—— | 2-[[5-(3-Methylanilino)-1,3,4-thiadiazol-2-yl]sulfanyl]acetamide | —— | C11H12N4OS2 |
|
—— | 2-[[5-(3-methylanilino)-1,3,4-thiadiazol-2-yl]sulfanyl]-N-propylacetamide | —— | C14H18N4OS2 |
|
—— | (2R)-2-[[5-(3-methylanilino)-1,3,4-thiadiazol-2-yl]sulfanyl]propanamide | —— | C12H14N4OS2 |
|
—— | (6S)-1,5,6,7-tetrahydroimidazo[2,1-b][1,3]thiazin-4-ium-6-ol | —— | C6H9N2OS+ |
|
—— | (2S)-2-[[5-(3-methylanilino)-1,3,4-thiadiazol-2-yl]sulfanyl]propanamide | —— | C12H14N4OS2 |
|
—— | (2S)-2-(4-bromophenyl)sulfanyl-N-cyclopentylpropanamide | —— | C14H18BrNOS |
|
—— | 2-[[5-(3-methylanilino)-1,3,4-thiadiazol-2-yl]sulfanyl]-N-(3-methylbutyl)acetamide | —— | C16H22N4OS2 |
|
—— | (2S)-2-(4-bromophenyl)sulfanyl-N-cyclopropylpropanamide | —— | C12H14BrNOS |
|
—— | 2-[[5-(3-methylanilino)-1,3,4-thiadiazol-2-yl]sulfanyl]-N-[(2S)-4-phenylbutan-2-yl]acetamide | —— | C21H24N4OS2 |
|
—— | 1-(Azepan-1-yl)-2-[[5-(3-methylanilino)-1,3,4-thiadiazol-2-yl]sulfanyl]ethanone | —— | C17H22N4OS2 |
|
—— | (2R)-2-(4-bromophenyl)sulfanyl-N-cyclopropylpropanamide | —— | C12H14BrNOS |
|
—— | N-benzyl-N-ethyl-2-[[5-(3-methylanilino)-1,3,4-thiadiazol-2-yl]sulfanyl]acetamide | —— | C20H22N4OS2 |
|
—— | 2-[[5-(3-methylanilino)-1,3,4-thiadiazol-2-yl]sulfanyl]-N-[(2R)-4-phenylbutan-2-yl]acetamide | —— | C21H24N4OS2 |
|
—— | N-(3-methylphenyl)-5-(2-methylsulfanylethylsulfanyl)-1,3,4-thiadiazol-2-amine | —— | C12H15N3S3 |
|
—— | N-[(1R)-1-cyano-1-cyclopropylethyl]-2-[[5-(4-methylanilino)-1,3,4-thiadiazol-2-yl]sulfanyl]acetamide | —— | C17H19N5OS2 |
|
—— | N-cyclohexyl-N-[(3S)-1,1-dioxothiolan-3-yl]-2-pyridin-2-ylsulfanylacetamide | —— | C17H24N2O3S2 |
|
—— | (3R)-3-[[5-(3,4-dimethylanilino)-1,3,4-thiadiazol-2-yl]sulfanyl]oxolan-2-one | —— | C14H15N3O2S2 |
|
—— | 3-(4-chlorophenyl)sulfanyl-N-(2-morpholin-4-ium-4-ylethyl)propanamide | —— | C15H22ClN2O2S+ |
|
—— | (2S)-2-[[5-(2-methylanilino)-1,3,4-thiadiazol-2-yl]sulfanyl]-1-pyrrolidin-1-ylpropan-1-one | —— | C16H20N4OS2 |
|
—— | ethyl N-[2-[[5-(3,4-dimethylanilino)-1,3,4-thiadiazol-2-yl]sulfanyl]acetyl]carbamate | —— | C15H18N4O3S2 |
|
—— | (2R)-2-[[5-(4-methylanilino)-1,3,4-thiadiazol-2-yl]sulfanyl]-1-pyrrolidin-1-ylpropan-1-one | —— | C16H20N4OS2 |
|
—— | N-cyclohexyl-N-[(3R)-1,1-dioxothiolan-3-yl]-2-pyridin-2-ylsulfanylacetamide | —— | C17H24N2O3S2 |
|